Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Lynne A, Lamb"'
Autor:
Caroline Von Althann, Wen-Jen Hwu, Philip H. Gutin, Drew E. Baldwin, Jeffrey J. Raizer, Lynne A. Lamb, Mark H. Bilsky, Gladys Alvarado, Katherine S. Panageas, Elizabeth Bailey, Andrew Wilton
Publikováno v:
Neuro-Oncology. 10:199-207
Brain metastases (BM) are among the most devastating and debilitating complications of melanoma. This retrospective study was conducted to gain a better understanding of patient and disease characteristics that have the greatest impact on overall sur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1272223a9f5cee28a8272619dc13bcea
https://doi.org/10.1215/15228517-2007-058
https://doi.org/10.1215/15228517-2007-058
Autor:
Paul B. Chapman, Alan N. Houghton, Lynne A. Lamb, Jennifer H. Menell, Wen Jen Hwu, Linda Williams, Katherine S. Panageas, Susan E. Krown, Suzan Aird, Philip O. Livingston, Jedd D. Wolchok
Publikováno v:
Cancer. 106:2445-2451
BACKGROUND Temozolomide and interferon-α-2b (IFN-α-2b) are both active in melanoma. Therefore, the efficacy and safety of temozolomide in combination with pegylated IFN-α-2b in patients with metastatic melanoma without brain metastases was investi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::269e9dcf1b66e0cc8aad570d8195b1ce
https://doi.org/10.1002/cncr.21909
https://doi.org/10.1002/cncr.21909
Autor:
Susan E. Krown, Eric Lis, Linda Williams, Paul B. Chapman, Wen Jen Hwu, Janene Merrell, Philip O. Livingston, Alan N. Houghton, Katherine S. Panageas, Lynne A. Lamb, Jennifer H. Menell, Jedd D. Wolchok
Publikováno v:
Cancer. 103:2590-2597
BACKGROUND Temozolomide plus thalidomide is a promising oral combination regimen for the treatment of metastatic melanoma. The current Phase II study examined the efficacy and safety of this combination in chemotherapy-naive patients with brain metas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b33cdc4f5808a6e82e61e9aa9daa928
https://doi.org/10.1002/cncr.21081
https://doi.org/10.1002/cncr.21081
Autor:
Jedd D. Wolchok, Jennifer H. Menell, Susan E. Krown, Lynne A. Lamb, Carolyn J. Quinn, Theresa Foster, Philip O. Livingston, Wen Jen Hwu, Janene Merrell, Linda Williams, Katherine S. Panageas, Paul B. Chapman, Alan N. Houghton
Publikováno v:
Journal of Clinical Oncology. 21:3351-3356
Purpose: To further investigate the efficacy and safety of temozolomide plus thalidomide in patients with metastatic melanoma without brain metastases. Patients and Methods: Patients with histologically confirmed advanced-stage metastatic melanoma we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e38dcb85ffe1af9e830c31433da54279
https://doi.org/10.1200/jco.2003.02.061
https://doi.org/10.1200/jco.2003.02.061
Autor:
Wen-Jen, Hwu, Katherine S, Panageas, Jennifer H, Menell, Lynne A, Lamb, Suzan, Aird, Susan E, Krown, Linda J, Williams, Paul B, Chapman, Philip O, Livingston, Jedd D, Wolchok, Alan N, Houghton
Publikováno v:
Cancer. 106(11)
Temozolomide and interferon-alpha-2b (IFN-alpha-2b) are both active in melanoma. Therefore, the efficacy and safety of temozolomide in combination with pegylated IFN-alpha-2b in patients with metastatic melanoma without brain metastases was investiga
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::be47e972c4c8adf703c76e2cb06f1223
https://pubmed.ncbi.nlm.nih.gov/16639739
https://pubmed.ncbi.nlm.nih.gov/16639739
Publikováno v:
Seminars in oncology nursing. 19(1)
Objectives To describe the clinical features and histologic subtypes of cutaneous melanoma; to review the diagnosis, clinical, and pathologic staging of melanoma and the associated prognostic factors; and to review the treatment and management of AJC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5da5a0e72b83a46c5bc4f129961e2a6b
https://pubmed.ncbi.nlm.nih.gov/12638378
https://pubmed.ncbi.nlm.nih.gov/12638378
Autor:
Paul B. Chapman, Jennifer H. Menell, P. O. Livingston, Susan E. Krown, Lynne A. Lamb, Linda Williams, Jedd D. Wolchok, W. Hwu, S. Aird, K. S. Panageas
Publikováno v:
Journal of Clinical Oncology. 22:7533-7533
7533 Background: Interferon-α (IFN) has some anti-tumor activity against melanoma, but has been used primarily at high, toxic doses. At low doses, IFN has antiangiogenic activity and has induced re...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::abbdb7e204a542e623a2c68f427ded56
https://doi.org/10.1200/jco.2004.22.90140.7533
https://doi.org/10.1200/jco.2004.22.90140.7533
Autor:
Wen‐Jen Hwu, Katherine S. Panageas, Jennifer H. Menell, Lynne A. Lamb, Suzan Aird, Susan E. Krown, Linda J. Williams, Paul B. Chapman, Philip O. Livingston, Jedd D. Wolchok, Alan N. Houghton
Publikováno v:
Cancer (0008543X); Jun2006, Vol. 106 Issue 11, p2445-2451, 7p
Autor:
Wen‐Jen Hwu, Eric Lis, Jennifer H. Menell, Katherine S. Panageas, Lynne A. Lamb, Janene Merrell, Linda J. Williams, Susan E. Krown, Paul B. Chapman, Philip O. Livingston, Jedd D. Wolchok, Alan N. Houghton
Publikováno v:
Cancer (0008543X); Jun2005, Vol. 103 Issue 12, p2590-2597, 8p